Dexamethasone dipropionateCAS# 55541-30-5 |
- Betamethasone 17,21-dipropionate
Catalog No.:BCC8875
CAS No.:5593-20-4
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 55541-30-5 | SDF | Download SDF |
PubChem ID | 63049 | Appearance | Powder |
Formula | C28H37FO7 | M.Wt | 504.6 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Methaderm | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | [2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-propanoyloxy-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] propanoate | ||
SMILES | CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC | ||
Standard InChIKey | CIWBQSYVNNPZIQ-PKWREOPISA-N | ||
Standard InChI | InChI=1S/C28H37FO7/c1-6-23(33)35-15-22(32)28(36-24(34)7-2)16(3)12-20-19-9-8-17-13-18(30)10-11-25(17,4)27(19,29)21(31)14-26(20,28)5/h10-11,13,16,19-21,31H,6-9,12,14-15H2,1-5H3/t16-,19+,20+,21+,25+,26+,27+,28+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Dexamethasone dipropionate Dilution Calculator
Dexamethasone dipropionate Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.9818 mL | 9.9088 mL | 19.8177 mL | 39.6354 mL | 49.5442 mL |
5 mM | 0.3964 mL | 1.9818 mL | 3.9635 mL | 7.9271 mL | 9.9088 mL |
10 mM | 0.1982 mL | 0.9909 mL | 1.9818 mL | 3.9635 mL | 4.9544 mL |
50 mM | 0.0396 mL | 0.1982 mL | 0.3964 mL | 0.7927 mL | 0.9909 mL |
100 mM | 0.0198 mL | 0.0991 mL | 0.1982 mL | 0.3964 mL | 0.4954 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Z-Lys(Boc)-OH
Catalog No.:BCC2763
CAS No.:2389-60-8
- H-Lys(Boc)-OMe.HCl
Catalog No.:BCC2983
CAS No.:2389-48-2
- Boc-Lys(Z)-OH
Catalog No.:BCC2722
CAS No.:2389-45-9
- Zapotinin
Catalog No.:BCC9192
CAS No.:14813-20-8
- Tosedostat (CHR2797)
Catalog No.:BCC2309
CAS No.:238750-77-1
- Ethyl2-bromo-4H-thieno[3,2-b]pyrrole-5-carboxylate
Catalog No.:BCC8979
CAS No.:238749-50-3
- Liensinine perchlorate
Catalog No.:BCN6335
CAS No.:2385-63-9
- Ambroxol HCl
Catalog No.:BCC5067
CAS No.:23828-92-4
- Ac-Trp-OEt
Catalog No.:BCC3110
CAS No.:2382-80-1
- Trichokaurin
Catalog No.:BCN4851
CAS No.:23811-50-9
- Hinesol
Catalog No.:BCC9232
CAS No.:23811-08-7
- Pogostone
Catalog No.:BCN2696
CAS No.:23800-56-8
- Alphaxalone
Catalog No.:BCC7545
CAS No.:23930-19-0
- 5-(2-Aminopropyl)-7-cyanoindolin-1-yl)propyl benzoate
Catalog No.:BCC8718
CAS No.:239463-72-0
- 5-[(2R)-2-Aminopropyl]-1-[3-(benzoyloxy)propyl]-2,3-dihydro-1H-indole-7-carbonitrile (2R,3R)-2,3-dihydroxybutanedioate
Catalog No.:BCN1479
CAS No.:239463-85-5
- Glochidonol
Catalog No.:BCN5091
CAS No.:23963-54-4
- 4,4'-Bis(5-methyl-2-benzoxazolyl)stilbene
Catalog No.:BCC8657
CAS No.:2397-00-4
- Meranzin
Catalog No.:BCN5092
CAS No.:23971-42-8
- Delta-9-Tetrahydrocannabinolic acid
Catalog No.:BCN8098
CAS No.:23978-85-0
- Tolnaftate
Catalog No.:BCC4869
CAS No.:2398-96-1
- 13-Deacetyltaxachitriene A
Catalog No.:BCN7390
CAS No.:239800-99-8
- Dehydroepiandrosterone enanthate
Catalog No.:BCC8930
CAS No.:23983-43-9
- Pyrocatechol monoglucoside
Catalog No.:BCN4667
CAS No.:2400-71-7
- QX 314 bromide
Catalog No.:BCC6889
CAS No.:24003-58-5
Dexamethasone dipropionate loaded nanoparticles of alpha-elastin-g-PLGA for potential treatment of restenosis.[Pubmed:24206105]
Mol Pharm. 2013 Dec 2;10(12):4603-10.
A graft copolymer of alpha-elastin with poly(lactic-co-glycolic) acid (PLGA) has been synthesized and successfully employed to produce nanoparticles. Exploiting the known biological activity of alpha-elastin to promote the maintenance of smooth muscle cells (SMCs) contractile phenotype and the antiproliferative effect of glucocorticoids, the aim of this research was to produce drug-loaded nanoparticles suitable for potential treatment of restenosis. In particular, nanoparticles of alpha-elastin-g-PLGA with a mean size of 200 nm have been produced and loaded with Dexamethasone dipropionate (10% w/w), chosen as a model drug that inhibits proliferation of vascular SMCs. These nanoparticles are able to prolong the drug release and show a pronounced sensibility to elastase. Drug unloaded nanoparticles stimulate the differentiation of human umbilical artery smooth muscle cells (HUASMCs) toward the contractile phenotype as demonstrated by immunofluorescence, flow cytofluorimetric, and western blotting analyses. Finally, drug-loaded nanoparticles efficiently reduce viability of HUASMCs as evidenced by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay.